anti-CD3/anti-5T4 bispecific T-cell engager UniAbs (TeneoBio)

N/A

Report date: 2026/03/19 16:58:33

Base Information

Drug Nameanti-CD3/anti-5T4 bispecific T-cell engager UniAbs (TeneoBio)
Drug Alias NameCD3 x 5T4 T-BsAb (TeneoBio)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsTrophoblast glycoprotein modulators
TargetsTrophoblast glycoproteinT cell surface glycoprotein CD3
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeneobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesTeneobio Inc
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A